Elevated Tissue Factor and TFPI Levels in Acute COPD Exacerbations: A Prospective Comparison With Stable COPD and Healthy Controls
Clinical and Applied Thrombosis/Hemostasis
Published online on July 17, 2026
Abstract
Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
PurposeThis prospective study aimed to evaluate tissue factor (TF) and tissue factor pathway inhibitor (TFPI) as potential biomarkers of hypercoagulability in patients with acute exacerbation of COPD (AECOPD), compared to stable COPD patients and healthy ...
PurposeThis prospective study aimed to evaluate tissue factor (TF) and tissue factor pathway inhibitor (TFPI) as potential biomarkers of hypercoagulability in patients with acute exacerbation of COPD (AECOPD), compared to stable COPD patients and healthy ...